Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

June 30, 2006

Conditions
Macular Edema
Interventions
DRUG

intravitreous triamcinolone

Intravenous injection of 0.1 ml (4 mg) of triamcinolone acetate was performed through the pars plana in a surgical environment. The medication used was manipulated by the Ophthalmos chemist. This type of formulation is different from the similar American one (Kenalog ®) since it does not use a conservation agent

PROCEDURE

laser therapy

pan fotocoaglulation by laser therapy

Trial Locations (3)

90630040

Hospital de Clínicas de Porto Alegre, Porto Alegre

90035-003

Hospital de Clínicas de Porto Alegre, Porto Alegre

9035/903

HOspital de Clínicas de Porto alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT00668239 - Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser | Biotech Hunter | Biotech Hunter